Skip to content
value.today
Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD
$367 Mmarket cap on Oct 15, 2026+23.6% since Jan 2024
1D
+0.9%
Compare
World rank
#13,910
Revenue
$270 M
For year ending December-2025
Net income
$15 M
5.5% margin
SEC filing
Employees
—

Viemed Healthcare, Inc. in brief

Viemed Healthcare, Inc. is a listed company in the Medical Equipment industry, based in Lafayette, Louisiana, USA. It was founded in 2006. Its market value was $367 M on 15 October 2026, which makes it the 13,910th largest listed company in the world and the 2,733rd largest in the USA on this site. In the year to December 2025 it had sales of $270 M and a net profit of $15 M, about 6 cents of profit for every dollar of sales. Casey Hoyt is its chief executive. Its largest product and service lines by sales in 2025 were Equipment and supply sales (19%). Its shares trade under the symbol VMD (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Viemed Healthcare, Inc.

Viemed Healthcare is Provides Home Respiratory Service company to patients struggling with various respiratory diseases including chronic obstructive pulmonary disease (COPD) and various neuromuscular diseases. The company annual revenue is 131.3 million USD, annual operating income is 26.7 million USD and annual net income is 31.5 million USD. The headquarters is in USA.

Viemed Healthcare, Inc. timeline

4 events, 2006–2025
  1. 2006
  2. 🏁
    · approximate
    Founded
  3. 2018
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2020
  6. 💰
    Record net income of $32 million
    FY2020, the highest profit of the 8 years on record.
  7. 2025
  8. 💰
    Record revenue of $270 million
    FY2025, the highest of the 8 years on record.

Events of Viemed Healthcare, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$99 M$198 M$297 M$397 M2020202120222023202420252026

World rank over time

▲ up 1,068 places since 2020
2020-01-01: #15021#15,02120202021-01-01: #13560#13,56020212022-01-07: #18472#18,47220222022-12-25: #16081#16,08120222023-07-30: #15026#15,02620232024-01-05: #15817#15,81720242026-03-08: #8093#8,09320262026-08-01: #13633#13,63320262026-10-13: #14029#14,02920262026-10-15: #13953#13,9532026

Rank in USA: #3,089 (Jan 2020) · #2,928 (Jan 2021) · #3,763 (Jan 2022) · #3,306 (Dec 2022) · #3,040 (Jul 2023) · #2,936 (Jan 2024) · #1,450 (Mar 2026) · #2,751 (Aug 2026) · #2,732 (Oct 2026) · #2,737 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
23.5×
Price / sales (TTM)
1.2×
Price / book
2.6×
Free cash flow yield
3.3%
Net margin (TTM)
5.0%
Operating margin
8.5%
Return on equity
11.0%
Liabilities / assets
27.9%
Net debt
$-2M
Revenue growth
+20.5%
R&D / revenue
1.1%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $64M, net income $10M$64MFY18Fiscal year ending Dec 2019: revenue $80M, net income $9M$80MFY19Fiscal year ending Dec 2020: revenue $131M, net income $32M$131MFY20Fiscal year ending Dec 2021: revenue $117M, net income $9M$117MFY21Fiscal year ending Dec 2022: revenue $139M, net income $6M$139MFY22Fiscal year ending Dec 2023: revenue $183M, net income $10M$183MFY23Fiscal year ending Dec 2024: revenue $224M, net income $11M$224MFY24Fiscal year ending Dec 2025: revenue $270M, net income $15M$270MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$270M+20.5%$23M$15M5.5%
Dec 2024$224M+22.5%$18M$11M5.0%
Dec 2023$183M+31.8%$14M$10M5.6%
Dec 2022$139M+18.6%$8M$6M4.5%
Dec 2021$117M-10.9%$12M$9M7.8%
Dec 2020$131M+63.6%$27M$32M24.0%
Dec 2019$80M+24.5%$9M$9M10.6%
Dec 2018$64M—$10M$10M14.8%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$52M$40M$12M$0.37—
Dec 2024$39M$38M$1M$0.28—
Dec 2023$45M$26M$19M$0.25—
Dec 2022$28M$23M$5M$0.16—
Dec 2021$22M$20M$3M$0.22—
Dec 2020$35M$13M$22M$0.78—
Dec 2019$19M$13M$6M$0.21—
Dec 2018$22M$6M$16M$0.24—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$310M
Net income, trailing 12 months
$16M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $61M, net income $4M$61MDec ’24Three months to Mar 2025: revenue $59M, net income $3M$59MMar ’25Three months to Jun 2025: revenue $63M, net income $3M$63MJun ’25Three months to Sep 2025: revenue $72M, net income $4M$72MSep ’25Three months to Dec 2025 (from the annual report): revenue $76M, net income $6M$76MDec ’25Three months to Mar 2026: revenue $75M, net income $3M$75MMar ’26Three months to Jun 2026: revenue $78M, net income $3M$78MJun ’26Three months to Sep 2026: revenue $81M, net income $5M$81MSep ’26

Latest quarter to Sep 2026: revenue $81M (+12.2% on a year earlier), net income $5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Viemed Healthcare, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$270 M
Operating income
$23 M
Net income
$15 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$199 M
Total liabilities
$56 M
Total equity
$142 M

As of December-2025

Top 100 institutional investors in Viemed Healthcare, Inc.#

As of Sep 30, 2026
168 institutions held 27.2 M shares (about 71.8% of the shares outstanding) on Sep 30, 2026. The ten largest hold 37.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Viemed Healthcare, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.4,942,634+154,327 (+3.22%)13.04%$45 MNov 13, 2026
2Forager Capital Management, LLC1,773,177-368,007 (-17.19%)4.68%$16 MNov 16, 2026
3Vanguard Capital Management LLC1,321,396-280 (-0.02%)3.49%$12 MNov 13, 2026
4Ameriprise Financial Inc1,300,898+294,703 (+29.29%)3.43%$12 MNov 16, 2026
5Geode Capital Management, LLC1,171,828+198,084 (+20.34%)3.09%$11 MNov 6, 2026
6Arrowstreet Capital, Limited Partnership1,043,664+257,395 (+32.74%)2.75%$9 MNov 13, 2026
7State Street Corp757,224-4,873 (-0.64%)2.00%$7 MNov 12, 2026
8Nantahala Capital Management, LLC714,674-550,216 (-43.50%)1.89%$7 MNov 13, 2026
9Martin & Co Inc /TN/701,680+360,909 (+105.91%)1.85%$6 MNov 12, 2026
10Panagora Asset Management Inc597,497+58,872 (+10.93%)1.58%$5 MNov 12, 2026
11Punch & Associates Investment Management, Inc.583,163+49,697 (+9.32%)1.54%$5 MNov 16, 2026
12Two Sigma Investments, LP579,608+140,757 (+32.07%)1.53%$5 MNov 16, 2026
13Goldman Sachs Group Inc578,962-643,572 (-52.64%)1.53%$5 MNov 16, 2026
14First Eagle Investment Management, LLC533,157-537,157 (-50.19%)1.41%$5 MNov 10, 2026
15Creative Planning486,304+125,948 (+34.95%)1.28%$4 MNov 2, 2026
16Acadian Asset Management LLC475,237+76,651 (+19.23%)1.25%$4 MNov 9, 2026
17Renaissance Technologies LLC465,957+40,057 (+9.41%)1.23%$4 MNov 12, 2026
18Algert Global LLC465,624New1.23%$4 MNov 17, 2026
19Vanguard Portfolio Management LLC423,642+142,309 (+50.58%)1.12%$4 MNov 13, 2026
20Qube Research & Technologies Ltd407,271New1.07%$4 MNov 13, 2026
21AQR Capital Management LLC393,202+187,722 (+91.36%)1.04%$4 MNov 16, 2026
22Raffles Associates LP392,761-414,621 (-51.35%)1.04%$4 MNov 16, 2026
23Bard Associates Inc338,961-711 (-0.21%)0.89%$3 MNov 13, 2026
24Penbrook Management LLC275,948-1,230 (-0.44%)0.73%$3 MOct 16, 2026
25Northern Trust Corp274,697+3,334 (+1.23%)0.72%$2 MNov 16, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Viemed Healthcare, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Millennium Management LLC272,119+220,170 (+423.82%)0.72%$2 MNov 16, 2026
27Tocqueville Asset Management L.P.272,100-70,000 (-20.46%)0.72%$2 MNov 13, 2026
28Morgan Stanley269,844-30,566 (-10.17%)0.71%$2 MNov 13, 2026
29Lazard Asset Management LLC253,211-9,275 (-3.53%)0.67%$2 MNov 16, 2026
30Vanguard Fiduciary Trust Co242,773+5,983 (+2.53%)0.64%$2 MNov 13, 2026
31Expect Equity LLC221,878+9,157 (+4.30%)0.59%$2 MNov 16, 2026
32State Board Of Administration Of Florida Retirement System210,001New0.55%$2 MNov 13, 2026
33Rice Hall James & Associates, LLC196,263-12,803 (-6.12%)0.52%$2 MNov 16, 2026
34Dimensional Fund Advisors LP189,9310 (0.00%)0.50%$2 MNov 4, 2026
35UBS Group AG170,449+91,736 (+116.54%)0.45%$2 MNov 10, 2026
36Y-Intercept (Hong Kong) Ltd170,411+142,297 (+506.14%)0.45%$2 MOct 16, 2026
37Trexquant Investment LP164,669+75,389 (+84.44%)0.43%$1 MNov 16, 2026
38Citadel Advisors LLC158,397-75,918 (-32.40%)0.42%$1 MNov 16, 2026
39Gsa Capital Partners LLP143,470+15,879 (+12.45%)0.38%$1 MNov 16, 2026
40Man Group plc139,830+45,742 (+48.62%)0.37%$1 MNov 16, 2026
41Point72 Asset Management, L.P.134,517-21,325 (-13.68%)0.35%$1 MNov 16, 2026
42Quantinno Capital Management LP134,180+16,470 (+13.99%)0.35%$1 MNov 13, 2026
43Bank of New York Mellon Corp105,089+15,091 (+16.77%)0.28%$1 MNov 5, 2026
44North Star Investment Management Corp.105,000+5,000 (+5.00%)0.28%$1 MOct 27, 2026
45Strs Ohio103,800+41,300 (+66.08%)0.27%$1 MOct 30, 2026
46Nuveen, LLC101,668-14,823 (-12.72%)0.27%$1 MNov 10, 2026
47Charles Schwab Investment Management Inc99,904+217 (+0.22%)0.26%$1 MNov 16, 2026
48Magnetar Financial LLC99,709+58,397 (+141.36%)0.26%$1 MNov 13, 2026
49Gabelli Funds LLC92,4000 (0.00%)0.24%$1 MNov 12, 2026
50Barclays PLC90,968+28,681 (+46.05%)0.24%$1 MNov 6, 2026
51Salem Investment Counselors Inc75,982+18,000 (+31.04%)0.20%$1 MOct 13, 2026
52Round Rock Advisors LLC69,2920 (0.00%)0.18%$1 MNov 12, 2026
53Mangrove Partners Im, LLC68,561-7,618 (-10.00%)0.18%$1 MNov 16, 2026
54Creative Planning Institutional Advisors, LLC68,549+41,922 (+157.44%)0.18%$1 MNov 16, 2026
55Campbell & CO Investment Adviser LLC67,150+6,300 (+10.35%)0.18%$1 MNov 13, 2026
56RBF Capital, LLC65,9720 (0.00%)0.17%$1 MNov 13, 2026
57Bank Of America Corp /de/56,875-101,887 (-64.18%)0.15%$1 MNov 16, 2026
58Russell Investments Group, Ltd.55,011+29,981 (+119.78%)0.15%$1 MNov 6, 2026
59Invesco Ltd.53,587+10,989 (+25.80%)0.14%$0 MNov 12, 2026
60Verdad Advisers, LP52,8790 (0.00%)0.14%$0 MNov 16, 2026
61Integrated Quantitative Investments LLC51,206-13,824 (-21.26%)0.14%$0 MNov 13, 2026
62HSBC Holdings PLC46,443+8,151 (+21.29%)0.12%$0 MNov 16, 2026
63Numerai GP LLC46,431-28,625 (-38.14%)0.12%$0 MNov 13, 2026
64Martingale Asset Management L P44,147+1,726 (+4.07%)0.12%$0 MNov 12, 2026
65State of Wyoming40,335New0.11%$0 MOct 28, 2026
66Rhumbline Advisers39,645-911 (-2.25%)0.10%$0 MNov 10, 2026
67Hillsdale Investment Management Inc.39,000-186,109 (-82.68%)0.10%$0 MNov 12, 2026
68BNP Paribas Financial Markets37,009-97,585 (-72.50%)0.10%$0 MNov 12, 2026
69UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC36,316+32,011 (+743.58%)0.10%$0 MNov 16, 2026
70Summit Global Investments36,1090 (0.00%)0.10%$0 MOct 28, 2026
71Engineers Gate Manager LP35,531-1,136 (-3.10%)0.09%$0 MNov 16, 2026
72Public Employees Retirement System Of Ohio32,528New0.09%$0 MNov 16, 2026
73Aristides Capital LLC30,494+13,481 (+79.24%)0.08%$0 MNov 16, 2026
74Deutsche Bank AG\29,744-4,138 (-12.21%)0.08%$0 MNov 6, 2026
75Rothschild Wealth LLC29,716-832 (-2.72%)0.08%$0 MNov 12, 2026
76Walleye Capital LLC29,365-154,544 (-84.03%)0.08%$0 MNov 13, 2026
77Price T Rowe Associates Inc /MD/27,9760 (0.00%)0.07%$0 MNov 16, 2026
78Seizert Capital Partners, LLC27,947-1,899 (-6.36%)0.07%$0 MOct 30, 2026
79Mercer Global Advisors Inc /adv27,362+4,770 (+21.11%)0.07%$0 MNov 16, 2026
80CenterBook Partners LP27,330New0.07%$0 MNov 2, 2026
81Semanteon Capital Management, LP26,796+6,925 (+34.85%)0.07%$0 MNov 9, 2026
82WINTON GROUP Ltd26,555New0.07%$0 MNov 12, 2026
83Squarepoint Ops LLC26,022+2,415 (+10.23%)0.07%$0 MNov 9, 2026
84Bridgeway Capital Management, LLC25,3910 (0.00%)0.07%$0 MNov 16, 2026
85SEI Investments Co25,207-48,358 (-65.74%)0.07%$0 MNov 10, 2026
86LPL Financial LLC23,886-106 (-0.44%)0.06%$0 MNov 6, 2026
87Vestcor Inc23,5630 (0.00%)0.06%$0 MNov 12, 2026
88BCM Advisors, LLC23,5200 (0.00%)0.06%$0 MNov 3, 2026
89MBB Public Markets I LLC23,3840 (0.00%)0.06%$0 MNov 16, 2026
90Blair William & Co/il23,129-374 (-1.59%)0.06%$0 MNov 10, 2026
91StoneX Group Inc.18,494New0.05%$0 MNov 3, 2026
92MetLife Investment Management, LLC18,1700 (0.00%)0.05%$0 MNov 16, 2026
93Spark Investment Management LLC18,100New0.05%$0 MNov 13, 2026
94Jpmorgan Chase & Co18,013-93,149 (-83.80%)0.05%$0 MNov 12, 2026
95Susquehanna International Group, LLP17,591-57,838 (-76.68%)0.05%$0 MNov 16, 2026
96Osaic Holdings, Inc.17,200-5,590 (-24.53%)0.05%$0 MNov 12, 2026
97MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.16,437+815 (+5.22%)0.04%$0 MNov 16, 2026
98Ulland Investment Advisors, LLC15,870-12,675 (-44.40%)0.04%$0 MOct 13, 2026
99Jump Financial, LLC15,659-10,715 (-40.63%)0.04%$0 MNov 13, 2026
100Diversified Trust Co15,597+3,980 (+34.26%)0.04%$0 MNov 6, 2026

All 168 institutional investors, with who bought and sold →

Mutual funds holding Viemed Healthcare, Inc.#

124 funds hold shares worth $80 M (about 23.9% of the company). Since their previous reports 62 added shares and 25 sold, buying $2 M net.
Mutual funds holding Viemed Healthcare, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.912,713$10 M3.0%<0.01%+0.3%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors870,045$10 M2.9%0.01%+7.3%Jun 30, 2026
🇺🇸 Columbia Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC566,630$7 M1.9%0.26%+6.5%Jul 31, 2026
🇺🇸 First Eagle Small Cap Opportunity FundFirst Eagle Investment Management, LLC467,300$5 M1.6%0.19%+1.1%Jul 31, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC485,288$5 M1.6%0.09%−1.3%May 29, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC372,227$4 M1.2%0.01%+13%Jul 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.373,459$4 M1.2%<0.01%+2.2%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors319,961$4 M1.1%0.02%+18%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.171,949$2 M0.57%<0.01%+1.2%May 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC170,736$2 M0.57%<0.01%−1.5%May 31, 2026
🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds124,615$1 M0.42%0.17%−27%Jun 30, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors114,129$1 M0.38%0.09%+35%Jun 30, 2026
🇺🇸 First Trust Dow Jones Select MicroCap Index FundFirst Trust Advisors L.P.110,694$1 M0.37%0.48%+5.2%Jun 30, 2026
🇺🇸 Fidelity SAI Small-Mid Cap Momentum Index FundFidelity Management & Research Company LLC101,049$1 M0.34%0.03%newJul 31, 2026
🇺🇸 Columbia Variable Portfolio - Small Cap Value Discovery FundColumbia Management Investment Advisers, LLC102,520$1 M0.34%0.26%−3.3%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.97,561$1 M0.33%0.11%−52%Jul 31, 2026
🇺🇸 The Canadian Small Company SeriesDimensional Fund Advisors LP93,487$1 M0.31%0.05%no changeJul 31, 2026
🇺🇸 North Star Micro Cap FundNorth Star Investment Management Corp.100,000$1 M0.33%0.53%no changeMay 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.83,102$1 M0.28%0.01%+11%Jul 31, 2026
🇺🇸 Gabelli Healthcare & WellnessRx TrustGabelli Funds, LLC85,000$1 M0.28%0.63%no changeJun 30, 2026
🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors65,414$1 M0.22%0.03%−24%Jun 30, 2026
🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS64,634$1 M0.22%0.34%−21%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.57,971$1 M0.19%0.21%−23%Jul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC59,015$1 M0.20%0.01%no changeJun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC63,614$1 M0.21%<0.01%no changeMay 31, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.54,636$1 M0.18%0.27%−17%Jun 30, 2026
🇺🇸 BlackRock Advantage SMID Cap Fund, Inc.BlackRock Advisors, LLC53,409$1 M0.18%0.06%no changeJun 30, 2026
🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc.45,874$1 M0.15%0.03%no changeJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC44,083$1 M0.15%<0.01%no changeJul 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.52,165$1 M0.17%0.05%+1.3%May 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC50,380$0 M0.17%<0.01%+4.5%May 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC41,144$0 M0.14%0.01%no changeJul 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC39,482$0 M0.13%0.01%+19%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.33,415$0 M0.11%<0.01%+4.5%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC31,923$0 M0.11%0.02%+25%Jun 30, 2026
🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC31,694$0 M0.11%0.26%−22%Jun 30, 2026
🇺🇸 SGI Small Cap Core FundRBB Fund, Inc.36,109$0 M0.12%0.27%+25%May 31, 2026
🇺🇸 Nationwide Bailard Small Cap Value FundNATIONWIDE FUND ADVISORS28,100$0 M0.09%0.25%newJul 31, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.31,155$0 M0.10%0.02%+0.7%May 31, 2026
🇺🇸 State Street SPDR US Small Cap Low Volatility Index ETFSSGA Funds Management, Inc.24,387$0 M0.08%0.11%newJun 30, 2026
🇺🇸 International Vector Equity PortfolioDimensional Fund Advisors LP23,412$0 M0.08%<0.01%no changeJul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation22,600$0 M0.08%0.01%−7.8%Jun 30, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC22,060$0 M0.07%<0.01%newJun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC24,506$0 M0.08%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC17,967$0 M0.06%<0.01%+5.9%Jul 31, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.17,649$0 M0.06%0.01%+24%Jun 30, 2026
🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC19,686$0 M0.07%<0.01%no changeMay 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC16,188$0 M0.05%0.01%+11%Jul 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.16,000$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.14,170$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.14,040$0 M0.05%<0.01%no changeJun 30, 2026
🇺🇸 BlackRock Advantage SMID Cap V.I. FundBlackRock Advisors, LLC13,349$0 M0.04%0.09%−27%Jun 30, 2026
🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC12,860$0 M0.04%<0.01%+127%Jul 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC12,516$0 M0.04%<0.01%+8.4%Jul 31, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors11,706$0 M0.04%<0.01%−0.8%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.11,600$0 M0.04%<0.01%−12%Jun 30, 2026
🇺🇸 AQR Small Cap Multi-Style FundAQR CAPITAL MANAGEMENT, LLC11,599$0 M0.04%0.03%+89%Jun 30, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company12,800$0 M0.04%<0.01%+1.7%May 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC10,554$0 M0.04%0.01%+30%Jun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC10,345$0 M0.03%0.01%−9.3%Jun 30, 2026
🇺🇸 Dimensional International Core Equity 2 ETFDimensional Fund Advisors LP9,492$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC9,600$0 M0.03%<0.01%+39%Jun 30, 2026
🇺🇸 International Small Cap Growth PortfolioDimensional Fund Advisors LP8,932$0 M0.03%0.03%no changeJul 31, 2026
🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC9,000$0 M0.03%0.02%no changeJun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION9,000$0 M0.03%<0.01%+800%May 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC7,750$0 M0.03%<0.01%−0.5%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC7,749$0 M0.03%0.01%+19%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS7,738$0 M0.03%0.01%+19%Jun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC7,613$0 M0.03%0.04%+27%Jun 30, 2026
🇺🇸 Gabelli Global Small & Mid Cap Value TrustGabelli Funds, LLC7,400$0 M0.02%0.06%no changeJun 30, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC6,960$0 M0.02%<0.01%+63%Jun 30, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP6,272$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC6,242$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP5,448$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.5,396$0 M0.02%0.01%+16%Jun 30, 2026
🇺🇸 Brighthouse/Dimensional International Small Company PortfolioBrighthouse Investment Advisers, LLC5,284$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC5,281$0 M0.02%0.01%+23%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.5,138$0 M0.02%0.01%+21%Jun 30, 2026
🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC5,024$0 M0.02%0.01%+0.6%Jul 31, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC5,103$0 M0.02%0.01%+18%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC4,857$0 M0.02%0.01%+31%Jun 30, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC4,262$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC4,178$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 Dimensional VA International Small PortfolioDimensional Fund Advisors LP4,100$0 M0.01%0.01%no changeJul 31, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC3,879$0 M0.01%0.01%no changeJul 31, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC3,210$0 M0.01%0.02%+44%Jun 30, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS3,139$0 M0.01%0.01%+32%Jul 31, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS3,114$0 M0.01%<0.01%+109%Jul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC2,938$0 M<0.01%<0.01%+30%Jul 31, 2026
🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC2,983$0 M<0.01%<0.01%newJun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management2,819$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC3,094$0 M0.01%0.01%−53%May 31, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC2,606$0 M<0.01%0.01%+11%Jun 30, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC2,601$0 M<0.01%0.01%no changeJun 30, 2026
🇺🇸 International Small Company TrustJohn Hancock Variable Trust Advisers LLC2,600$0 M<0.01%0.03%no changeJun 30, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.2,259$0 M<0.01%<0.01%+6.8%May 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC1,840$0 M<0.01%<0.01%−25%Jun 30, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC1,600$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust1,648$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC1,576$0 M<0.01%<0.01%+6.5%May 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Viemed Healthcare, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$1.6 M
9 sales, 3 insiders
Net, 12 months
-$1.6 M
open market only
Insiders on file
13
since
$20 K-$1.6 M$0May 2024: bought $20 K (3 trades), sold $0 (0 trades)May 24Nov 2024: bought $0 (0 trades), sold $1.4 M (7 trades)NovMar 2025: bought $0 (0 trades), sold $91 K (5 trades)MarJun 2025: bought $0 (0 trades), sold $1.6 M (6 trades)JunAug 2025: bought $0 (0 trades), sold $403 K (3 trades)AugMar 2026: bought $0 (0 trades), sold $1.2 M (3 trades)MarJun 2026: bought $0 (0 trades), sold $347 K (6 trades)Jun
Bought (open market)Sold (open market)Hover a month for the totals
Viemed Healthcare, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Timothy SmokoffDirectorOption exercise+15,029——90,547Form 4
filed Sabrina HeltzDirectorOption exercise+15,029——82,520Form 4
filed Randy E. DobbsDirectorOption exercise+16,763——142,253Form 4
filed Nitin KaushalDirectorOption exercise+18,786——161,361Form 4
filed Sabrina HeltzDirectorOption exercise+3,757——86,277Form 4
filed Timothy SmokoffDirectorOption exercise+3,757——94,304Form 4
filed Randy E. DobbsDirectorOption exercise+4,191——146,444Form 4
filed Sabrina HeltzDirectorDisposal to the company-3,757$8.940$34 K82,520Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Viemed Healthcare, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
1.5 M
4.0% of shares · 8.51 days to cover
Buybacks, Q3 2026
$1M
Q3 2026
Shares sold short, last 24 reportsAll stocks →
Viemed Healthcare, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q3 2026Q3 2026$1M
Q2 2026Q2 2026$5.3M
Q1 2026Q1 2026$1.4M
Q4 2025Q4 2025$0M
Q3 2025Q3 2025$11.6M
Q2 2025Q2 2025$1.7M
Q1 2025Q1 2026$0M
Q4 2024Q4 2024$0M
Q3 2024Q3 2025$0M
Q4 2023Q4 2023$0M
Q3 2023Q3 2023$0M
Q2 2023Q2 2023$0M
Q1 2023Q1 2023$0M
Q4 2022Q4 2022$0.7M
Q3 2022Q3 2022$1.9M
Q2 2022Q2 2022$5.1M

Fails to deliver

  • : 544 shares at $9.69
  • : 370 shares at $9.60
  • : 612 shares at $9.13
  • : 711 shares at $9.23
  • : 102 shares at $8.85

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Viemed Healthcare, Inc. scorecard#

Passes 21 of the 26 checks that could be worked out: strongest in financial health (5 of 5), weakest in valuation (4 of 6). Fiscal year 2025; market cap of Oct 15, 2026.

  • Valuation4 of 6
    • ✓P/E below its peers' median23.5×P/E 23.5× against Healthcare's median of 30.0×.
    • ✓Price to book below its peers' median2.6×Price to book 2.6× against Healthcare's median of 3.1×.
    • ✓Price to sales below its peers' median1.2×Price to sales 1.2× against Healthcare's median of 3.8×.
    • ✗Free cash flow yield above 5%3.2%Free cash flow is 3.2% of the market value.
    • ✗Earnings yield above the 10-year Treasury yield4.3%Earnings yield 4.3% against the 10-year Treasury's 5.15% on 2026-11-13.
    • ✓The price assumes slower growth than the last three years'15.2%The price assumes 15.2% a year for ten years; revenue grew 24.9% a year over the last three.
  • Growth5 of 6
    • ✓Revenue grew in the newest year20.5%Revenue up 20.5% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years24.9%24.9% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median24.9%24.9% a year against Medical Equipment's median of 24.7% (5 companies).
    • ✓Earnings per share grew in the newest year0.37 vs 0.28Diluted EPS 0.37 in fiscal 2025 against 0.28 the year before (report's currency).
    • ✗Net income higher than five years earlier$15 M$15 M in fiscal 2025 against $32 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability5 of 6
    • ✓Profitable in the newest year$15 MNet income $15 M in fiscal 2025.
    • ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median8.5%8.5% against Medical Equipment's median of -38.5% (8 companies).
    • ✗Return on equity above 15%10.9%10.9% in fiscal 2025.
    • ✓Return on invested capital above 10%12.6%12.6% in fiscal 2025.
    • ✓Operating margin wider than three years earlier8.5%8.5% in fiscal 2025 against 5.9% in 2022.
  • Financial health5 of 5
    • ✓Short-term assets cover short-term liabilities1.2×Current ratio 1.18 at the end of fiscal 2025.
    • ✓Debt below equity0.1×Debt to equity 0.08 at the end of fiscal 2025.
    • ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $2 M at the end of fiscal 2025.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone6.47Z-score 6.47 (safe zone) for fiscal 2025.
  • Shareholder returns2 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year0.1%Diluted shares up 0.1% in fiscal 2025.
    • ✓Dividends and buybacks above 3% of the market value3.6%Dividends and buybacks were 3.6% of the market value.
    • ✗Free cash flow covers dividends and buybacks$12 MFree cash flow $12 M against $13 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Viemed Healthcare, Inc.'s statements, beside the median of Medical Equipment.

Viemed Healthcare, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin8.5%-38.5%
Net margin5.5%-44.9%
Return on equity10.9%-94.5%
Revenue growth, 3 years a year24.9%24.7%
Revenue growth20.5%15.6%
Debt to equity0.08×—

6of 9on the Piotroski tests of financial strength

  • Revenue has grown 4 years in a row.
  • Free cash flow has been positive 8 years in a row.
  • More cash than debt: net cash of $2 million.

Viemed Healthcare, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Viemed Healthcare, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018
Income statement
Revenue2702241831391171318064
Cost of revenue11591705444512417
Gross profit1551331138573805648
Research and development3.03.12.82.72.11.10.80
Selling, general and administrative121106886855534134
Operating income2318148.312278.9r10
Share of profit of associates0−1.00.50.91.20.1−0.1—
Other non-operating income (expense)0.3−0.20.11.01.64.0−0.0—
Income before tax2216149.013268.89.7
Income tax6.44.84.12.83.4−5.20.30.2
Net income including minority interests1511106.2————
Minority interests' share of net income0.40.100————
Net income attributable to shareholders1511106.29.1328.59.5
Earnings per share, basic0.380.290.270.160.230.810.230.25
Earnings per share, diluted0.370.280.250.160.220.780.210.24
Shares, weighted average (basic)3939383939393838
Shares, weighted average (diluted)4141404041414040
Balance sheet
Cash and cash equivalents1418131728311310
Receivables262518151312128.8
Inventory5.04.34.63.62.52.31.42.9
Other current assets4.16.12.43.81.71.51.61.0r
Current assets4853384047472823r
Property, plant and equipment79767468r63555531
Right-of-use (leased) assets3.62.82.90.7————
Goodwill5933300————
Other intangible assets1.30.80.60————
Investments in associates——0.30.81.00.1r0.0—
Non-current assets1511241177771655531
Total assets1991771551171181138354r
Accounts payable7.35.34.22.73.22.14.75.9
Debt due within a year1.10.41.101.51.81.80
Current liabilities4137321918232620r
Long-term debt113.66.004.35.87.60
Lease liabilities (non-current)2.42.02.20.2————
Non-current liabilities156.48.91.15.37.9131.5
Total liabilities5644412023313921r
Retained earnings10390797073663427r
Shareholders' equity1421311149795824433r
Minority interests2.01.90—————
Total equity1441331149795———
Total liabilities and equity1991771551171181138354r
Shares outstanding3839393840393838
Cash-flow statement
Depreciation and amortization29252216————
Share-based compensation9.16.35.85.25.24.93.92.7
Cash from operating activities5239452822351922
Capital expenditure−40−38−26−23−20−13−13−6.1
Acquisitions, net of cash acquired−26−3.0−290————
Cash from investing activities−50−31−52−24−20−8.4−13−5.3
Debt issued——————5.00
Debt repaid——————−0.40
Shares bought back−1300−9.60r0−1.5−1.6
Cash from financing activities−5.8−3.72.8−15−5.3−9.1−3.3−12
Change in cash−4.04.7−4.1−11−2.6182.95.3
Report10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Viemed Healthcare, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Equipment and supply sales$50 M19%
  • Service revenues(total)$25 M9.2%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Executive pay at Viemed Healthcare, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$2.6 M
Casey Hoyt
Other top executives, average
$2.0 M
the CEO earned 1.3× this
$100 invested is now
$142
peer group: $100
Viemed Healthcare, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Casey Hoyt$2.6 M$2.3 M$2.0 M$142 (peers $100)
2024Casey Hoyt$2.6 M$2.5 M$1.5 M$154 (peers $85)
2023Casey Hoyt$2.5 M$2.5 M$1.4 M$150 (peers $84)
2022Casey Hoyt$1.9 M$2.8 M$1.1 M$145 (peers $80)

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Viemed Healthcare, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 4 · Material agreement 3 · New debt 1 · Shareholder vote 3 · Results announced 10

Viemed Healthcare, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Directors and officersShareholder vote8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Directors and officersShareholder vote8-K
Material agreementNew debt8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026

Acquisitions and funding#

2 acquisitions, $59 M paid where reported · 1 private funding rounds before listing

Businesses it acquired

Acquisitions by Viemed Healthcare, Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Lehan Drugs, Inc2025—$29 M100%Annual report
Home Medical Products Inc2023—$29 M100%Annual report

Private share sales · funding history

Private share sales of Viemed Healthcare, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2018$3 MNo. 1$2 to $10 million5optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by Viemed Healthcare, Inc.#

$0 spent on lobbying the US Congress and federal agencies in 2022.

Lobbying, 2022
$0
#1,452 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2022
2026 so far
—

Lobbying firms hired in 2022

Forbes-Tate

Viemed Healthcare, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2022$0—3
2021$0—4
2020$130 K—2

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “VieMed Healthcare, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

How Viemed Healthcare, Inc. compares in Medical Equipment

  • Market cap$367 M · higher than 86% of 8
  • Revenue$270 M · higher than 83% of 19
  • Net margin5.0% · higher than 75% of 17
  • Revenue growth20.5% · higher than 75% of 13
  • Price / sales1.2× · lower than 50% of 7
  • Price / book2.6× · lower than 50% of 7
  • FCF yield3.3% · highest of 7

Peer comparison · Medical Equipment

CompanyMarket capP/ENet marginRev. growth
Viemed Healthcare, Inc.🇺🇸$367 M23.5×5.0%+20.5%
Avita Medical, Inc.🇺🇸$525 M—-42.6%+11.5%
Electromed, Inc.🇺🇸$341 M28.6×15.8%+15.3%
Profound Medical Corp.🇨🇦$240 M—-137.4%+50.8%
Streamex Corp.🇺🇸$52 M——+100.0%
TELA Bio, Inc.🇺🇸$52 M—-53.6%+15.8%
IRIDEX Corporation🇺🇸$12 M—-6.9%+8.2%
Beyond Air, Inc.🇺🇸$4 M—-407.6%+107.6%
Varian Medical Systems🇺🇸$16.3 B—8.5%-1.8%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 15, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Viemed Healthcare, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Viemed Healthcare, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Viemed Healthcare, Inc.? Suggest a correction